SageView Advisory Group »

Corvus Pharmaceuticals shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $231 30 7.70

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Perceptive Advisors
Foresite Capital Management VI
DCF Advisers
Susquehanna International
Goldman Sachs Group
Logos Global Management

View all funds holding Corvus Pharmaceuticals